Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Shinjiro Sakamoto, Masanori Noguchi, Akira Yamada, Kyogo Itoh & Tetsuro Sasada. (2016) Prospect and progress of personalized peptide vaccinations for advanced cancers. Expert Opinion on Biological Therapy 16:5, pages 689-698.
Read now
Read now
Junya Ohtake, Satoshi Wada, Erika Yada, Yuki Fujimoto, Hidemi Uchiyama, Shintaro Yoshida, Kyogo Itoh & Tetsuro Sasada. (2016) Personalized immunotherapy in colorectal cancer. Expert Review of Precision Medicine and Drug Development 1:3, pages 267-277.
Read now
Read now
Tetsuro Sasada, Masanori Noguchi, Akira Yamada & Kyogo Itoh. (2012) Personalized peptide vaccination: A novel immunotherapeutic approach for advanced cancer. Human Vaccines & Immunotherapeutics 8:9, pages 1309-1313.
Read now
Read now
Rahul Aggarwal & Andrea Harzstark. (2010) Research Highlights. Personalized Medicine 7:5, pages 479-483.
Read now
Read now
Articles from other publishers (58)
KEIKO ODA, YASUHIKO ITO, AKIRA YAMADA, SHIGERU YUTANI, KYOGO ITOH & SHUICHI OZONO. (2021) Evaluation of the Immunological Response of Childhood Cancer Patients Treated with a Personalized Peptide Vaccine for Refractory Soft Tissue Tumor: A Four-Case Series. The Kurume Medical Journal 68:2, pages 157-163.
Crossref
Crossref
Shuko Saku, Uhi Toh, Yuko Takao, Sayaka Sakurai, Akira Yamada, Shigeki Shichijo, Kyogo Itoh & Yoshito Akagi. (2021) Plasma level of prostate related‑antigen peptide‑reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines. Experimental and Therapeutic Medicine 22:2.
Crossref
Crossref
Masanori Noguchi, Gaku Arai, Shin Egawa, Chikara Ohyama, Seiji Naito, Kazumasa Matsumoto, Hirotsugu Uemura, Masayuki Nakagawa, Yasutomo Nasu, Masatoshi Eto, Shigetaka Suekane, Tetsuro Sasada, Shigeki Shichijo, Akira Yamada, Tatsuyuki Kakuma & Kyogo Itoh. (2020) Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial. Cancer Immunology, Immunotherapy 69:5, pages 847-857.
Crossref
Crossref
Anuj Tewari, Beenu Jain & Ashok Kumar Bhatia. (2019) Multiplexed DIVA tests for rapid detection of FMDV infection/circulation in endemic countries. Applied Microbiology and Biotechnology 104:2, pages 545-554.
Crossref
Crossref
Kee Thai Yeo, Paula Embury, Timothy Anderson, Peter Mungai, Indu Malhotra, Christopher King, James Kazura & Arlene Dent. (2019) HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates. The Journal of Immunology 202:5, pages 1465-1478.
Crossref
Crossref
Masanori Noguchi, Noriko Koga, Fukuko Moriya, Shigetaka Suekane, Shigeru Yutani, Akira Yamada, Shigeki Shichijo, Tatuyuki Kakuma & Kyogo Itoh. (2018) Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers. Cancer Science 109:9, pages 2660-2669.
Crossref
Crossref
Satoko Matsueda, Kyogo Itoh & Shigeki Shichijo. (2018) Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte‐specific protein tyrosine kinase. Cancer Science 109:3, pages 611-617.
Crossref
Crossref
P. Minakshi, Anuj Tiwari, Beenu Jain & Gaya Prasad. 2018. Advances in Animal Biotechnology and its Applications. Advances in Animal Biotechnology and its Applications
197
210
.
Noriko Koga, Fukuko Moriya, Kayoko Waki, Akira Yamada, Kyogo Itoh & Masanori Noguchi. (2017) Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine. Cancer Science 108:12, pages 2326-2332.
Crossref
Crossref
Shinjiro Sakamoto, Teppei Yamada, Yasuhiro Terazaki, Koichi Yoshiyama, Shunichi Sugawara, Shinzo Takamori, Satoko Matsueda, Shigeki Shichijo, Akira Yamada, Masanori Noguchi, Kyogo Itoh, Noboru Hattori, Nobuoki Kohno & Tetsuro Sasada. (2017) Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer. Clinical Lung Cancer 18:6, pages e385-e394.
Crossref
Crossref
Takahiro Kimura, Shin Egawa & Hirotsugu Uemura. (2017) Personalized peptide vaccines and their relation to other therapies in urological cancer. Nature Reviews Urology 14:8, pages 501-510.
Crossref
Crossref
Masato Yokomine, Satoko Matsueda, Kouichiro Kawano, Tetsuro Sasada, Akimasa Fukui, Takuto Yamashita, Nobukazu Komatsu, Shigeki Shichijo, Kazuto Tasaki, Ken Matsukuma, Kyogo Itoh, Toshiharu Kamura & Kimio Ushijima. (2017) Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females. Experimental and Therapeutic Medicine 13:4, pages 1500-1505.
Crossref
Crossref
Ahidjo Ayouba, Abdoulaye Touré, Christelle Butel, Alpha Kabinet Keita, Florian Binetruy, Mamadou S. Sow, Vincent Foulongne, Eric Delaporte & Martine Peeters. (2017) Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus. Journal of Clinical Microbiology 55:1, pages 165-176.
Crossref
Crossref
Shinjiro Sakamoto, Shigeru Yutani, Shigeki Shichijo, Michi Morita, Akira Yamada, Kyogo Itoh & Masanori Noguchi. (2016) Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site. Cancer Immunology, Immunotherapy 65:10, pages 1223-1231.
Crossref
Crossref
Masanori Noguchi, Fukuko Moriya, Noriko Koga, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Tatsuyuki Kakuma & Kyogo Itoh. (2016) A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer. Cancer Immunology, Immunotherapy 65:2, pages 151-160.
Crossref
Crossref
Koichi Takayama, Shunichi Sugawara, Yasuo Saijo, Makoto Maemondo, Atsushi Sato, Shinzo Takamori, Taishi Harada, Tetsuro Sasada, Tatsuyuki Kakuma, Junji Kishimoto, Akira Yamada, Masanori Noguchi, Kyogo Itoh & Yoichi Nakanishi. (2016) Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer. Journal of Immunology Research 2016, pages 1-7.
Crossref
Crossref
Shinjiro Sakamoto, Satoko Matsueda, Shinzo Takamori, Uhi Toh, Masanori Noguchi, Shigeru Yutani, Akira Yamada, Shigeki Shichijo, Teppei Yamada, Shigetaka Suekane, Kouichiro Kawano, Tetsuro Sasada, Noboru Hattori, Nobuoki Kohno & Kyogo Itoh. (2015)
Immunological evaluation of peptide vaccination for cancer patients with the
HLA
‐A26 allele
. Cancer Science 106:10, pages 1257-1263.
Crossref
Crossref
Masanori Noguchi, Gaku Arai, Kazumasa Matsumoto, Seiji Naito, Fukuko Moriya, Shigetaka Suekane, Nobukazu Komatsu, Satoko Matsueda, Tetsuro Sasada, Akira Yamada, Tatsuyuki Kakuma & Kyogo Itoh. (2015) Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression. Cancer Immunology, Immunotherapy 64:4, pages 493-505.
Crossref
Crossref
TEPPEI YAMADA, YASUHIRO TERAZAKI, SHINJIRO SAKAMOTO, KOICHI YOSHIYAMA, SATOKO MATSUEDA, NOBUKAZU KOMATSU, KAYOKO WAKI, AKIRA YAMADA, AKIHIKO KAWAHARA, MASAYOSHI KAGE, SHUNICHI SUGAWARA, YUICHI YAMASHITA, TETSURO SASADA, SHINZO TAKAMORI & KYOGO ITOH. (2015) Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens. International Journal of Oncology 46:1, pages 55-62.
Crossref
Crossref
Min-Suk Jeong & Dae-Ro Ahn. (2015) A microwell plate-based multiplex immunoassay for simultaneous quantitation of antibodies to infectious viruses. The Analyst 140:6, pages 1995-2000.
Crossref
Crossref
Shiro Kibe, Shigeru Yutani, Satoru Motoyama, Takanobu Nomura, Natsuki Tanaka, Akihiko Kawahara, Tomohiko Yamaguchi, Satoko Matsueda, Nobukazu Komatsu, Masatomo Miura, Yudai Hinai, Satoshi Hattori, Akira Yamada, Masayoshi Kage, Kyogo Itoh, Yoshito Akagi & Tetsuro Sasada. (2014) Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer. Cancer Immunology Research 2:12, pages 1154-1162.
Crossref
Crossref
Ryuji Takahashi, Uhi Toh, Nobutaka Iwakuma, Miki Takenaka, Hiroko Otsuka, Mina Furukawa, Teruhiko Fujii, Naoko Seki, Akihiko Kawahara, Masayoshi Kage, Satoko Matsueda, Yoshito Akagi, Akira Yamada, Kyogo Itoh & Tetsuro Sasada. (2014) Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients. Breast Cancer Research 16:4.
Crossref
Crossref
Wei Wu, Shuo Zhang, Jing Qu, Quanfu Zhang, Chuan Li, Jiandong Li, Cong Jin, Mifang Liang & Dexin Li. (2014) Simultaneous detection of IgG antibodies associated with viral hemorrhagic fever by a multiplexed Luminex-based immunoassay. Virus Research 187, pages 84-90.
Crossref
Crossref
Koichi Azuma, Nobukazu Komatsu, Satoshi Hattori, Satoko Matsueda, Akihiko Kawahara, Tetsuro Sasada, Kyogo Itoh & Tomoaki Hoshino. (2014) Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib. PLoS ONE 9:1, pages e86667.
Crossref
Crossref
Jane Christopher-HenningsKarla P. C. AraujoCarlos J. H. SouzaYing FangSteven LawsonEric A. NelsonTravis ClementMichael DunnJoan K. Lunney. (2013) Opportunities for bead-based multiplex assays in veterinary diagnostic laboratories. Journal of Veterinary Diagnostic Investigation 25:6, pages 671-691.
Crossref
Crossref
Satoko Matsueda, Nobukazu Komatsu, Kenichi Kusumoto, Shintaro Koga, Akira Yamada, Ryoko Kuromatsu, Shingo Yamada, Ritsuko Seki, Shigeru Yutani, Shigeki Shichijo, Takashi Mine, Takaaki Fukuda, Takashi Okamura, Seiya Okuda, Michio Sata, Junichi Honda, Masahide Kaji, Kyogo Itoh & Tetsuro Sasada. (2013) Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases. Developmental & Comparative Immunology 41:1, pages 68-76.
Crossref
Crossref
Masanori Noguchi, Tetsuro Sasada & Kyogo Itoh. (2012) Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine. Cancer Immunology, Immunotherapy 62:5, pages 919-929.
Crossref
Crossref
Shigeru Yutani, Nobukazu Komatsu, Satoko Matsueda, Munehiro Yoshitomi, Takahisa Shirahama, Akira Yamada, Kyogo Itoh & Tetsuro Sasada. (2013) Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients’ Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-10.
Crossref
Crossref
Sherry A. Dunbar & Michaela R. Hoffmeyer. 2013. The Immunoassay Handbook. The Immunoassay Handbook
157
174
.
Nobukazu Komatsu, Satoko Matsueda, Masanori Noguchi, Akira Yamada, Kyogo Itoh & Tetsuro Sasada. 2013. Molecular Vaccines. Molecular Vaccines
361
369
.
Akimasa Fukui, Satoko Matsueda, Kouichiro Kawano, Naotake Tsuda, Nobukazu Komatsu, Shigeki Shichijo, Tetsuro Sasada, Satoshi Hattori, Kimio Ushijima, Kyogo Itoh & Toshiharu Kamura. (2012) Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides. Virology Journal 9:1.
Crossref
Crossref
Masanori Noguchi, Fukuko Moriya, Shigetaka Suekane, Kei Matsuoka, Gaku Arai, Satoko Matsueda, Tetsuro Sasada, Akira Yamada & Kyogo Itoh. (2011) Phase II study of personalized peptide vaccination for castration‐resistant prostate cancer patients who failed in docetaxel‐based chemotherapy. The Prostate 72:8, pages 834-845.
Crossref
Crossref
Yasuhiro Terazaki, Koichi Yoshiyama, Satoko Matsueda, Noriko Watanabe, Akihiko Kawahara, Yoshiki Naito, Shigetaka Suekane, Nobukazu Komatsu, Tetsuya Ioji, Akira Yamada, Takashi Mine, Mizuhiko Terasaki, Kyogo Itoh, Shinzo Takamori & Tetsuro Sasada. (2012) Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer. Cancer Science 103:4, pages 638-644.
Crossref
Crossref
MUNEHIRO YOSHITOMI, SHIGERU YUTANI, SATOKO MATSUEDA, TETSUYA IOJI, NOBUKAZU KOMATSU, SHIGEKI SHICHIJO, AKIRA YAMADA, KYOGO ITOH, TETSURO SASADA & HISAFUMI KINOSHITA. (2012) Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis. Experimental and Therapeutic Medicine 3:3, pages 463-469.
Crossref
Crossref
Kazumasa Matsumoto, Masanori Noguchi, Takefumi Satoh, Ken‐Ichi Tabata, Tetsuo Fujita, Masatsugu Iwamura, Akira Yamada, Nobukazu Komatsu, Shiro Baba & Kyogo Itoh. (2010) A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin. BJU International 108:6, pages 831-838.
Crossref
Crossref
Sina Haeri, Nell Johnson, Arthur M. Baker, Alison M. Stuebe, Christena Raines, David A. Barrow & Kim A. Boggess. (2011) Maternal Depression and Epstein-Barr Virus Reactivation in Early Pregnancy. Obstetrics & Gynecology 117:4, pages 862-866.
Crossref
Crossref
Masanori Noguchi, Hirotsugu Uemura, Seiji Naito, Hideyuki Akaza, Akira Yamada & Kyogo Itoh. (2010) A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low‐dose estramustine in HLA‐A24‐positive patients with castration‐resistant prostate cancer. The Prostate 71:5, pages 470-479.
Crossref
Crossref
Mizuhiko TerasakiSoichiro ShibuiYoshitaka NaritaTakamitsu FujimakiTomokazu AokiKoji KajiwaraYutaka SawamuraKaoru KurisuToshihiro MinetaAkira YamadaKyogo Itoh. (2011) Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme. Journal of Clinical Oncology 29:3, pages 337-344.
Crossref
Crossref
Elena Ambrosino, Chloé Dumoulin, Eve Orlandi-Pradines, Franck Remoue, Aissatou Toure-Baldé, Adama Tall, Jean Biram Sarr, Anne Poinsignon, Cheikh Sokhna, Karine Puget, Jean-François Trape, Aurélie Pascual, Pierre Druilhe, Thierry Fusai & Christophe Rogier. (2010) A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malaria Journal 9:1.
Crossref
Crossref
Tetsuro Sasada, Nobukazu Komatsu, Shigetaka Suekane, Akira Yamada, Masanori Noguchi & Kyogo Itoh. (2010) Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines. European Journal of Cancer 46:9, pages 1514-1519.
Crossref
Crossref
Masanori Noguchi. (2010) Personalized peptide vaccination for urological cancer. Drug Delivery System 25:2, pages 103-109.
Crossref
Crossref
Takashi Hattori, Takashi Mine, Nobukazu Komatsu, Akira Yamada, Kyogo Itoh, Hitoshi Shiozaki & Kiyotaka Okuno. (2009) Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients. Cancer Immunology, Immunotherapy 58:11, pages 1843-1852.
Crossref
Crossref
Erwan Piriou, Rhonda Kimmel, Kiprotich Chelimo, Jaap M. Middeldorp, Peter Sumba Odada, Robert Ploutz‐Snyder, Ann M. Moormann & Rosemary Rochford. (2009) Serological evidence for long‐term epstein–barr virus reactivation in children living in a holoendemic malaria region of Kenya. Journal of Medical Virology 81:6, pages 1088-1093.
Crossref
Crossref
Joanne Ayriss, Rosa Valero, Andrew R.M. Bradbury & Peter Pavlik. 2009. Therapeutic Antibodies. Therapeutic Antibodies
241
260
.
Shojiro GoharaShigeki ShichijoNobukazu KomatsuSeiya OkudaShigeru YutaniKyogo Itoh. (2008) Detection of IgE Antibody Specific to a Hepatitis C Virus–Derived Peptide Being Recognized by Cellular Immunity in Patients with HCV Infection. Viral Immunology 21:3, pages 365-370.
Crossref
Crossref
M Naito, Y Komohara, Y Ishihara, M Noguchi, Y Yamashita, T Shirakusa, A Yamada, K Itoh & M Harada. (2007) Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles. British Journal of Cancer 97:12, pages 1648-1654.
Crossref
Crossref
Julie Perkins, Satya Parida & Alfonso Clavijo. (2007) Use of a Standardized Bovine Serum Panel To Evaluate a Multiplexed Nonstructural Protein Antibody Assay for Serological Surveillance of Foot-and-Mouth Disease. Clinical and Vaccine Immunology 14:11, pages 1472-1482.
Crossref
Crossref
Yuji Sato, Toshiyoshi Fujiwara, Takashi Mine, Hiroki Shomura, Shigenori Homma, Yoshiaki Maeda, Naoyuki Tokunaga, Yoshihiro Ikeda, Yuki Ishihara, Akira Yamada, Noriaki Tanaka, Kyogo Itoh, Mamoru Harada & Satoru Todo. (2007) Immunological evaluation of personalized peptide vaccination in combination with a 5‐fluorouracil derivative (TS‐1) for advanced gastric or colorectal carcinoma patients. Cancer Science 98:7, pages 1113-1119.
Crossref
Crossref
Hiroaki Yanagimoto, Takashi Mine, Koutaro Yamamoto, Sohei Satoi, Naoyoshi Terakawa, Kanji Takahashi, Kimika Nakahara, Shigenori Honma, Masahiro Tanaka, Junko Mizoguchi, Akira Yamada, Masaaki Oka, Yasuo Kamiyama, Kyogo Itoh & Soichiro Takai. (2007) Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer. Cancer Science 98:4, pages 605-611.
Crossref
Crossref
Joanne Ayriss, Travis Woods, Andrew Bradbury & Peter Pavlik. (2007) High-Throughput Screening of Single-Chain Antibodies Using Multiplexed Flow Cytometry. Journal of Proteome Research 6:3, pages 1072-1082.
Crossref
Crossref
Alexandra Adams & Kim D. Thompson. (2006) Biotechnology offers revolution to fish health management. Trends in Biotechnology 24:5, pages 201-205.
Crossref
Crossref
Yi Wang, Yukari Takao, Mamoru Harada, Nobukazu Komatsu, Takeharu Ono, Michio Sata, Kyogo Itoh & Akira Yamada. (2006) Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients. Cellular Immunology 241:1, pages 38-46.
Crossref
Crossref
MASAHIRO TANAKA, NOBUKAZU KOMATSU, YASUAKI YANAGIMOTO, MASAO OKA, SHIGEKI SHICHIJO, SEIYA OKUDA & KYOGO ITOH. (2006) Development of a New Diagnostic Tool for Pancreatic Cancer: Simultaneous Measurement of Antibodies against Peptides Recognized by Cytotoxic T Lymphocytes. The Kurume Medical Journal 53:3/4, pages 63-70.
Crossref
Crossref
Imran H. Khan, Sara Mendoza, JoAnn Yee, Matthew Deane, Kodumudi Venkateswaran, Shan S. Zhou, Peter A. Barry, Nicholas W. Lerche & Paul A. Luciw. (2006) Simultaneous Detection of Antibodies to Six Nonhuman-Primate Viruses by Multiplex Microbead Immunoassay. Clinical and Vaccine Immunology 13:1, pages 45-52.
Crossref
Crossref
Naoki Yajima, Ryuya Yamanaka, Takashi Mine, Naoto Tsuchiya, Jumpei Homma, Masakazu Sano, Terukazu Kuramoto, Yayoi Obata, Nobukazu Komatsu, Yoshimi Arima, Akira Yamada, Minoru Shigemori, Kyogo Itoh & Ryuichi Tanaka. (2005) Immunologic Evaluation of Personalized Peptide Vaccination for Patients with Advanced Malignant Glioma. Clinical Cancer Research 11:16, pages 5900-5911.
Crossref
Crossref
Tracey L. Bonfield, Nejimol John, Barbara P. Barna, Mani S. Kavuru, Mary Jane Thomassen & Belinda Yen-Lieberman. (2005) Multiplexed Particle-Based Anti-Granulocyte Macrophage Colony Stimulating Factor Assay Used as Pulmonary Diagnostic Test. Clinical and Vaccine Immunology 12:7, pages 821-824.
Crossref
Crossref
Imran H. Khan, Lon V. Kendall, Melanie Ziman, Scott Wong, Sara Mendoza, James Fahey, Stephen M. Griffey, Stephen W. Barthold & Paul A. Luciw. (2005) Simultaneous Serodetection of 10 Highly Prevalent Mouse Infectious Pathogens in a Single Reaction by Multiplex Analysis. Clinical and Vaccine Immunology 12:4, pages 513-519.
Crossref
Crossref
S. Shichijo, N. Keicho, H.T. Long, T. Quy, N.C. Phi, L.D. Ha, V.V. Ban, S. Itoyama, C.‐J. Hu, N. Komatsu, T. Kirikae, F. Kirikae, S. Shirasawa, M. Kaji, T. Fukuda, M. Sata, T. Kuratsuji, K. Itoh & T. Sasazuki. (2004) Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity. Tissue Antigens 64:5, pages 600-607.
Crossref
Crossref